Transaction #21734 · Form 4 · 0001437749-25-038138
Monopar Therapeutics · Other acquisition · Common Stock
Monopar Therapeutics · Transacted December 16, 2025 · Filed December 17, 2025
What does this filing report?
An SEC Form 4 filing for Monopar Therapeutics records an other acquisition involving Common Stock on December 16, 2025. The reported quantity was 7,710. The filing date is December 17, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Monopar Therapeutics
- Company CIK
- 0001645469
- Security type
- Non-derivative
- Acquisition type
- Other acquisition · Code J
- Quantity acquired
- 7,710
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 13,883
- Ownership description
- Not reported
- SEC acceptance time
- Dec 17, 2025, 3:41 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- KLAUSNER ARTHUR J ↗
Director
CIK 0001207790
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- Pro rata distribution from Gem Pharmaceuticals, LLC, of which the reporting person is a non-managing member.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.